GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tead1 | rn6_v1_chr1_+_177569618_177569618 | 0.68 | 1.3e-44 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_21854763 Show fit | 45.18 |
ENSRNOT00000089196
ENSRNOT00000020528 |
connective tissue growth factor |
|
chr1_+_214203861 Show fit | 39.80 |
ENSRNOT00000023219
|
Ras association domain family member 7 |
|
chr11_+_64522130 Show fit | 39.41 |
ENSRNOT00000004315
|
uroplakin 1B |
|
chr18_+_57286322 Show fit | 39.15 |
ENSRNOT00000026174
|
SH3 domain and tetratricopeptide repeats 2 |
|
chr16_+_47368768 Show fit | 38.24 |
ENSRNOT00000017966
|
WW and C2 domain containing 2 |
|
chr13_-_108841482 Show fit | 36.78 |
ENSRNOT00000004632
ENSRNOT00000086775 |
protein tyrosine phosphatase, non-receptor type 14 |
|
chr10_-_88874528 Show fit | 32.42 |
ENSRNOT00000026783
|
polymerase I and transcript release factor |
|
chr20_-_3605638 Show fit | 32.11 |
ENSRNOT00000074460
|
surfactant associated 2 |
|
chr6_+_109617596 Show fit | 30.97 |
ENSRNOT00000085031
ENSRNOT00000089972 ENSRNOT00000082402 |
feline leukemia virus subgroup C cellular receptor family, member 2 |
|
chr10_+_84182118 Show fit | 30.24 |
ENSRNOT00000011027
|
homeo box B3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 60.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
5.8 | 58.3 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 49.9 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
9.0 | 45.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 44.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 39.4 | GO:0030855 | epithelial cell differentiation(GO:0030855) |
3.6 | 39.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.9 | 36.8 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.5 | 32.7 | GO:0070527 | platelet aggregation(GO:0070527) |
7.6 | 30.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 79.7 | GO:0005856 | cytoskeleton(GO:0005856) |
0.4 | 48.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 46.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 46.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.8 | 45.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 39.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 37.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
6.0 | 29.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.5 | 29.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 28.0 | GO:0005829 | cytosol(GO:0005829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 69.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
6.5 | 58.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 49.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.5 | 38.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 38.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 30.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.5 | 26.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.9 | 26.2 | GO:0001968 | fibronectin binding(GO:0001968) |
1.5 | 24.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
6.0 | 23.9 | GO:0030172 | troponin C binding(GO:0030172) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 50.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.9 | 45.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 28.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.2 | 20.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 20.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 19.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 19.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 19.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.6 | 18.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 17.7 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 46.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.6 | 45.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.2 | 40.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.2 | 33.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.5 | 32.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.7 | 23.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.7 | 20.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 20.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.9 | 19.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 19.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |